| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a4b1eac93fa8426bfd541c9e14e11860
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ef5f43ae520d1136f9da40e34774ba1 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 |
| filingDate |
2010-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa7d9325c1e4e5162a3c042a210644e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e72b4e991099b7a4e456cdf5c4b91ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_355167728e6adcd3835cff5520df12d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da876f25c19b808f2c886291bcc305b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9115e1ad4752d74f3800087d66d064d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5659579e1881da51ec1bd8c0040224ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33617608416244ec5f1c82cbf42d0e5d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22df54e5b25db288075be4bbf63c5d50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd0c797b8103eed048ed90ef8f0710eb |
| publicationDate |
2014-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-102453028-B |
| titleOfInvention |
Antifungal agent 2-[(2,3-dihydro-4H-benzo-[b]thiapyran-4-ylidene) hydrazono]-4-oxotetrahydro thiazole (oxazole)-5-acetic acid derivative |
| abstract |
The invention relates to the technical field of medicines, in particular relates to a 2-[(2,3-dihydro-4H-benzo-[b]thiapyran-4-ylidene) hydrazono]-4-oxotetrahydro thiazole (oxazole)-5-acetic acid derivative or a salt thereof and a preparation method thereof, and also relates to a medicine taking the derivative or salt thereof as an active ingredient. Results of a test used for testing in vitro anti-fungal activity of the compound provided by the invention by adopting a two-fold concentration dilution method show that the compound has strong killing effect on clinically common pathogenic fungi and can overcome the defects that azoles antifungal drugs which are widely used clinically at present have high toxic and side effects, easily generate drug resistance and the like. |
| priorityDate |
2010-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |